| 1 |
Efficacy and Safety of Tumour Necrosis Factor-a Antagonists for Folliculitis Decalvans: A Retrospective Case-series Pilot Study |
|
| | Aurore Dupont, Alexia Eyraud, Brigitte Milpied, Sylvie De Bataille, Eline Cassassa, Anne-Sophie Darrigade, Thomas Barnetche, Marie-Sylvie Doutre, Bruno Matard, Marie Beylot-Barry, Julien Seneschal | | | Acta Dermato-Venereologica. 2023; 103: adv3713 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Refractory folliculitis decalvans treated with biologics: Case series in 4 situations |
|
| | Alejandro Lobato-Berezo, Ramon M. Pujol | | | Dermatologic Therapy. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Therapy-refractory folliculitis decalvans treated with certolizumab pegol |
|
| | Matthias Hoy, Markus Böhm | | | International Journal of Dermatology. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Oral isotretinoin for the treatment of dermatologic conditions other than acne: a systematic review and discussion of future directions |
|
| | Sherman Chu, Lauren Michelle, Chloe Ekelem, Calvin T. Sung, Nathan Rojek, Natasha A. Mesinkovska | | | Archives of Dermatological Research. 2021; 313(6): 391 | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Alopécie cicatricielle à type de folliculite décalvante induite par l’erlotinib |
|
| | C. Dervout, A.-M. Chiappa, C. Fleuret, P. Plantin, M. Acquitter | | | Annales de Dermatologie et de Vénéréologie. 2020; 147(12): 848 | | | [Pubmed] [Google Scholar] [DOI] | |
|
